CA
PRME icon

Cliff Asness’s Prime Medicine PRME Stock Holding History

Cliff Asness’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$435K Sell
117,998
-436,937
-79% -$1.45M ﹤0.01% 3454
2026
Q1 		$1.93M Buy
554,935
+139,114
+33% +$529K ﹤0.01% 2375
2025
Q4 		$1.44M Buy
415,821
+1,610
+0.4% +$7.16K ﹤0.01% 2341
2025
Q3 		$2.29M Sell
414,211
-10,144
-2% -$41.2K ﹤0.01% 1901
2025
Q2 		$1.05M Buy
424,355
+180,560
+74% +$278K ﹤0.01% 2182
2025
Q1 		$485K Buy
243,795
+227,749
+1,419% +$581K ﹤0.01% 2440
2024
Q4 		$46.9K Buy
+16,046
New +$56.3K ﹤0.01% 2811
2024
Q3 		– Sell
-34,268
Closed -$176K – 2857
2024
Q2 		$176K Buy
+34,268
New +$208K ﹤0.01% 2443

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Cliff Asness's PRME Position: Q2 2026 in Review

Cliff Asness reduced its Prime Medicine (PRME) stake by 79% in Q2 2026, selling an estimated $1.45M and leaving 117,998 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

Cliff Asness first reported a position in PRME in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.29M in Q3 2025. 186 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Cliff Asness held 117,998 shares of Prime Medicine worth $435K as of Q2 2026.
  • Cliff Asness sold 436,937 Prime Medicine shares in Q2 2026, an estimated $1.45M.
  • Prime Medicine made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3454 holding.
  • Cliff Asness first reported a position in Prime Medicine in Q2 2024 and has held it in 8 quarters since.
  • Cliff Asness's Prime Medicine position peaked at $2.29M in Q3 2025.
  • 186 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.